Results 1 to 10 of about 20,658 (229)

Calcium pyrophosphate deposition disease. [PDF]

CMAJ
Calcium pyrophosphate deposition (CPPD) disease is a consequence of the immune response to the pathological presence of calcium pyrophosphate (CPP) crystals inside joints, which causes acute or chronic inflammatory arthritis.
Kwok TSH, Choy G.
europepmc   +10 more sources

Calcium pyrophosphate deposition disease: historical overview and potential gaps. [PDF]

Front Med (Lausanne)
CPPD disease can affect patients’ quality of life through its various clinical presentations. This mini-review discusses the evolution of CPPD from its discovery to current knowledge of its pathogenesis, genetic associations, diagnostics, and treatment ...
Pineda C, Sandoval H, Pérez-Neri I, Soto-Fajardo C, Carranza-Enríquez F.   +4 more
europepmc   +3 more sources

Imaging and management of calcium pyrophosphate deposition disease. [PDF]

Skeletal Radiol
The radiological manifestations of calcium pyrophosphate deposition (CPPD) revolve around two main axes: the asymptomatic form and CPPD disease. The latter is a consequence of an immune response to calcium phosphate crystals. Chondrocalcinosis is broadly considered the radiographic manifestation of CPPD regardless of whether it is asymptomatic or ...
Issa W, Mercer R, Yinh J, Guermazi A, Jarraya M.   +4 more
europepmc   +4 more sources

The translational value of calcium pyrophosphate deposition disease experimental mouse models. [PDF]

Front Med (Lausanne)
The deposition of calcium pyrophosphate (CPP) crystals in joint tissues causes acute and chronic arthritis that commonly affect the adult and elderly population.
Luisetto R, Scanu A.
europepmc   +3 more sources

Editorial: Calcium pyrophosphate deposition disease. [PDF]

Front Med (Lausanne)
Filippou G, Dalbeth N, Tedeschi SK.
europepmc   +4 more sources

The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease. [PDF]

Ann Rheum Dis, 2023
Objective Calcium pyrophosphate deposition (CPPD) disease is prevalent and has diverse presentations, but there are no validated classification criteria for this symptomatic arthritis.
Abhishek A, Tedeschi SK, Pascart T, Latourte A, Dalbeth N, Neogi T, Fuller A, Rosenthal A, Becce F, Bardin T, Ea HK, Filippou G, Fitzgerald J, Iagnocco A, Lioté F, McCarthy GM, Ramonda R, Richette P, Sivera F, Andrés M, Cipolletta E, Doherty M, Pascual E, Perez-Ruiz F, So A, Jansen TL, Kohler MJ, Stamp LK, Yinh J, Adinolfi A, Arad U, Aung T, Benillouche E, Bortoluzzi A, Dau J, Maningding E, Fang MA, Figus FA, Filippucci E, Haslett J, Janssen M, Kaldas M, Kimoto M, Leamy K, Navarro GM, Sarzi-Puttini P, Scirè C, Silvagni E, Sirotti S, Stack JR, Truong L, Xie C, Yokose C, Hendry AM, Terkeltaub R, Taylor WJ, Choi HK.   +56 more
europepmc   +4 more sources

Dynamic assessment of the double contour sign by ultrasonography helps to distinguish between gout and calcium pyrophosphate deposition disease. [PDF]

RMD Open, 2023
Objective To test whether the double contour (DC) sign has a different dynamic behaviour in gout and calcium pyrophosphate deposition (CPPD) and whether the dynamic assessment of the DC sign increases its accuracy in gout diagnosis.
Cipolletta E, Abhishek A, Di Matteo A, Grassi W, Filippucci E.   +4 more
europepmc   +2 more sources

High prevalence of chondrocalcinosis and frequent comorbidity with calcium pyrophosphate deposition disease in patients with seronegative rheumatoid arthritis. [PDF]

RMD Open, 2022
Background The crystal-induced calcium pyrophosphate deposition disease (CPPD) clinically appearing as pseudogout differs from the mere radiographic finding of chondrocalcinosis (CC) but may cause symptoms resembling rheumatoid arthritis (RA).
Krekeler M, Baraliakos X, Tsiami S, Braun J.   +3 more
europepmc   +2 more sources

Calcium pyrophosphate crystal deposition disease—what’s new? [PDF]

Exploration of Musculoskeletal Diseases, 2023
Calcium pyrophosphate crystal deposition disease (CPPD) is a prevalent inflammatory rheumatic musculoskeletal disease (RMD) that has recently gained more scientific interest than before.
Jürgen Braun
doaj   +2 more sources

Trunnionosis in total hip arthroplasty with accompanying amyloidosis and calcium pyrophosphate deposition disease. [PDF]

Radiol Case Rep, 2023
Metal-on-polyethylene (MoP) is a common type of total hip arthroplasty. Trunnionosis is a rare but concerning complication of this type of implant. Trunnionosis involves wear and corrosion at the femoral component's head-neck interface and may cause a ...
Serdysnki KC, Kaplan S, Oraham A, Mirgati S, Akili F, Allam E.   +5 more
europepmc   +2 more sources